Telcon Inc (200230) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Telcon Inc KRW 3,978, price KRW 2,275, upside +74.9%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range 1,841 KRW – 141,531 KRW · fair‑value band 3,853 KRW – 4,088 KRW · the 2,275 KRW price screens below the 3,978 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Telcon in your weekly email
Every Wednesday you see whether Telcon is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc.
Show more
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
Stock analysis
Telcon Inc (200230) currently trades at 2,275 KRW, while our model-based Fair Value estimate is 3,978 KRW, implying the stock looks roughly 42.8% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 16,854 KRW per share, and 13 of the 13 models we run sit above the 2,275 KRW price.
Bear case: the Earnings-Based group reads lowest at 4,613 KRW, and 0 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: 3,853 KRW (bear) to 4,088 KRW (bull), the price of 2,275 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Telcon Inc reported revenue of 43.2B KRW in FY2025 versus 37.8B KRW in FY2021, a compound +3.3%/yr. Reported net income was −11.5B KRW in FY2025.
Key figures
Market cap 15.6B KRW (≈ $11.6M) · P/S ratio 0.26 · Net margin −26.5% · Return on equity −32.7% · Return on assets (EBIT) −4.2% · Operating margin −2.8% · Revenue (TTM) 61.8B KRW · Revenue growth (YoY) +189%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 81% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 75%, 200230 screens cheaper than that median.
Fair Value models
Bear 3,853 KRWFair Value 3,978 KRWBull 4,088 KRW
Price 2,275 KRW · Upside +74.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.42/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+14.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
Start year 2020 (pandemic). Over 10 years: +4.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−26.7% (2019) → −0.2% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+13.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +11.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 602 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Telcon Inc Fair Value". https://www.fairvalue-calculator.com/stock/200230
Frequently asked questions
Is Telcon Inc (200230) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 3,978 KRW versus a price of 2,275 KRW, about +75% upside (undervalued).
What is the fair value of 200230?
Our model-based fair value for Telcon Inc is 3,978 KRW (as of Oct 3, 2026), built from audited fundamentals. The current price: 2,275 KRW.
What is the quality score of 200230?
Telcon Inc has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Telcon Inc (200230)?
Our model-based price target is the fair value of 3,978 KRW (as of Oct 3, 2026) from 13 valuation models. Cautious scenario 3,853 KRW, optimistic scenario 4,088 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Telcon Inc stock forecast for 2026?
Our models put fair value at 3,978 KRW, about +75% upside versus a price of 2,275 KRW (undervalued). Cautious scenario 3,853 KRW, optimistic scenario 4,088 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Telcon Inc (200230)?
Telcon Inc reported trailing-twelve-month revenue of about 61.8B KRW (latest available figure, as of Oct 3, 2026).
What growth is priced into Telcon Inc (200230)?
For today's price to be fair in a discounted-cash-flow model, Telcon Inc would have to grow free cash flow by +13.3 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.4 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of 200230 use?
Our models discount Telcon Inc at 8.9 %: a base by market capitalisation (nano), damped by beta 0.41, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Telcon Inc that is +13.3 % per year a year over ten years, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Telcon Inc (200230) delivered so far?
Over the past 5 years revenue at Telcon Inc grew +5.4 % a year. The price currently implies +13.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Telcon Inc (200230) growing?
The median revenue growth in the sector is +10.3 % a year. That is the yardstick for the growth priced into Telcon Inc (+13.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Telcon Inc (200230)?
The free-cash-flow yield on the price is 8.64 %: that much free cash flow Telcon Inc produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Telcon Inc (200230)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Telcon Inc it is 3,978 KRW per share (as of Oct 3, 2026), against a price of 2,275 KRW. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Telcon Inc stock overvalued or undervalued in 2026?
As of Oct 3, 2026, 200230 trades below its calculated fair value: price 2,275 KRW, fair value 3,978 KRW, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 200230?
No. The price is what the market pays today (2,275 KRW); the fair value is what the company's own numbers justify (3,978 KRW). For Telcon Inc the two are 1,703 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Telcon Inc worth?
The market values Telcon Inc at about 15.6B KRW (market capitalisation, as of Oct 3, 2026). Per share that is 2,275 KRW; our models calculate a fair value of 3,978 KRW per share.
What do the bullish and bearish scenarios say about 200230?
Our models span a range for Telcon Inc: cautious scenario 3,853 KRW, base 3,978 KRW, optimistic 4,088 KRW per share (as of Oct 3, 2026, price 2,275 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Telcon Inc (200230)?
Balance-sheet figures for Telcon Inc (as of Oct 3, 2026): return on equity −32.7%. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 200230 from its 52-week high?
Telcon Inc trades at 2,275 KRW, about 81% below its 52-week high of 12,130 KRW and 24% above the low of 1,841 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 3,978 KRW is for.
Which stocks are comparable to Telcon Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Telcon Inc stock attractive at the current price?
The data as of Oct 3, 2026: price 2,275 KRW, calculated fair value 3,978 KRW (+75%), Quality Score 42/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 200230 calculated?
We run Telcon Inc through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3,978 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Telcon Inc currently trades 43 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Telcon Inc (200230)?
The closing price on Oct 2, 2026 was 2,275 KRW. Our model-based fair value is 3,978 KRW, about +75% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Telcon Inc right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (3,853 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (3,853 KRW to 4,088 KRW), unusually little disagreement for a valuation.
Key figures of Telcon Inc
How large is the market capitalisation of Telcon Inc (200230)?
The market capitalisation of Telcon Inc is 15.6B KRW (≈ $11.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Telcon Inc (200230)?
The price-to-sales ratio of Telcon Inc is 0.26 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Telcon Inc (200230)?
The net margin of Telcon Inc is −26.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Telcon Inc (200230)?
The return on equity (ROE) of Telcon Inc is −32.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Telcon Inc (200230)?
On an EBIT basis the return on assets of Telcon Inc is −4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Telcon Inc (200230)?
The operating margin of Telcon Inc is −2.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Telcon Inc (200230)?
Revenue at Telcon Inc is growing +189% versus a year earlier (3y avg +15.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Telcon Inc (200230)?
Earnings per share at Telcon Inc are growing +952% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Telcon Inc (200230) carry?
The net debt of Telcon Inc is 6.2B KRW (fiscal year 2025, ≈ 4.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Telcon Inc in the live analysis
One click puts Telcon Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
